Thromb Haemost 1989; 62(04): 1151
DOI: 10.1055/s-0038-1647137
Letter to the Editor
Schattauer GmbH Stuttgart

Time Dependent Factor IX Inhibitor

Ravindra Sarode
The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
,
A P Chauhan
The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
,
Mr Joseph
The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
,
Neelam Marwaha
The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
,
S K Sharma
The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
,
S Dash
The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
› Author Affiliations
Further Information

Publication History

Received 26 May 1989

Accepted after revision 27 September 1989

Publication Date:
24 July 2018 (online)

 
  • References

  • 1 Hassan HJ, Leonardie A, Gueeriero R. et al Hemophilia ‘B’ with inhibitor: molecular analysis of the subtotal deletion of factor IX gene. Blood 1985; 66: 728-730
  • 2 Shapiro SS. Antibodies to blood coagulation factor. Clinics Hematol 1979; 08 (01) 210
  • 3 Gadarowski Jr JJ, Czapek EE, Ontiveros JD, Pedraza JL. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficacy. Acta Hematol 1988; 80: 134-138